Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.
Back to all posts
Press Release
AlphaLogix announces market release of AlphaFlo® canine allograft
You may want to read these articles
RenoVō® vs. Alpha2EQ®: Comparing Equine Regenerative Options for Veterinary Use
As equine regenerative therapy evolves, veterinarians have more tools available to support tissue health. Two such products, RenoVō® and Alpha2EQ®, offer distinct biological compositions and clinical utility. Understanding their differences helps equine practitioners...
RenoVō® Case Study: Inner Ear Squamous Cell Carcinoma
Case presentation: On November 3, 2022, a 13 year-old Gelding Grade Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a mass in the right inner ear. The attending veterinarian, Dr. Audrey Turbeville, performed an excisional biopsy for pathology and...